Renal Business Today

Heparin

Researchers Find New Way to Make Heparin

TROY, N.Y.—Researchers have discovered an entirely new process to manufacture ultra-low molecular weight heparin, according to a study in the Oct. 28 issue of Science. ...More
November 1, 2011
Posted in News, Clinical & Pharma
B. Braun Recalls 7 Lots of Possibly Tainted Heparin

B. Braun Medical has recalled seven lots of heparin due to the possibility they were tainted. ...More
October 28, 2010
Posted in Blog, Government & Regulation
Fresenius, Interface Biologics Sign Technology Deal

TORONTO—Fresenius Medical Care has signed a deal to evaluate Interface Biologics Inc.’s Endexo technology, which is an alternative to heparin coatings used to prevent thrombus in medical devices. ...More
July 20, 2010
Posted in News, Business
FDA Clears APP Heparin Lock Flush Solution

SCHAUMBURG, Ill.—The U.S. Food and Drug Administration has cleared APP Pharmaceuticals to market its preservative-free Heparin Lock Flush Solution, USP in two dosage strengths, 10 USP Units/1 mL and 100 USP Units/1 mL, and will soon launch these single dose vial ...More
July 6, 2010
Posted in News, Clinical & Pharma, Government & Regulation
Baxter Faces Heparin Lawsuits

The Chicago Tribune is reporting that Baxter International, Inc., may face multiple lawsuits stemming from its 2008 voluntary recall of heparin that led to allergic reactions and death. The paper cited a law firm that said as many as 300 product-liability complaints may be ...More
January 13, 2010
Posted in News, Business, Clinical & Pharma, Government & Regulation
Lawsuit Filed against Heparin Maker, Dialysis Center

The family of Lloyd James Robinson, who allegedly died after he was administered heparin during treatment at the DaVita Lufkin Dialysis, filed a product liability lawsuit in the Beaumont Division of the Eastern District of Texas on Dec. 30 against the drug's manufacturer ...More
January 7, 2010
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
FDA Approves APP’s Generic Hypertension, Fluid Retention Drug

SCHAUMBURG, Ill.— The U.S. Food and Drug Administration has approved APP Pharmaceutical’s Chlorothiazide Sodium for Injection, USP, which is used to treat high blood pressure , as well as fluid retention in people with congestive heart failure, cirrhosis of the liver, ...More
October 21, 2009
Posted in News, Business, Clinical & Pharma, Government & Regulation
Contaminated Heparin Syringes Emphasize Safety Protocols

An outbreak of bloodstream infections appears to have been caused by the contamination of pre-filled heparin and saline syringes made by a single company. The subsequent investigation revealed that the company was not in compliance with safety regulations and identified ...More
October 14, 2009
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
Fresenius to Nationally Market Advanced Renal’s Citrasate

WALTHAM, Mass.—Fresenius Medical Care and Advanced Renal Technologies have signed an agreement under which Fresenius will supply and distribute Citrasate and DRYalysate in the United States. ...More
July 2, 2009
Posted in News, Business, Clinical & Pharma
FDA Sets New Standards for Heparin, Glycerin

ROCKVILLE, Md.—In a continuing effort to prevent counterfeit and adulterated medications from reaching American consumers, the U.S. Food and Drug Administration (FDA) is adopting stricter standards for heparin and glycerin—two widely used drug products at the center of ...More
February 5, 2009
Posted in News, Clinical & Pharma, Government & Regulation

featured links

HOT TOPICS

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Heparin

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail